Fritextsökning
Innehållstyper
-
Continuous sampling allows for instantaneous microbial detection
Biovigilant's IMD-A instruments employ an optical technology to continuously sample the air and immediately warn when microbial contamination is detected.
-
Årets Salss handlar om hjärnan
Årets toppmöte för företagare, världsledande forskare och läkare samlas nu för ett tre dagars konvent i Stockholm. Arrangören Barbro Ehnbom har ett tydligt mål ...
-
Your partnering tool - step by step
Profile, agenda and requests. Those are the basic steps to follow to use the partnering tool for Biotech Forum. Follow our guide to successful partnering!
-
Academia - a strong player on the lab market
While the industry was short of money during the financial crisis, government incentives were in full swing in Sweden during 2009. - Our sales to academia incre...
-
One-step cleaning system for use in clean rooms
The Micronswep cleaning system from Berendsen is a single action cleaning system developed for use in clean rooms.
-
TV: Mjukvaruföretag går in i USA
Svenskt företag med stödsytem för läkemedelsutveckling år in i USA. Detta är framgångsfaktorerna.
-
This is Sweden's largest life science region
About 60 percent of all jobs within swedish life science are found in the Stockholm-Uppsala area. This was stated in a report presented at Scanlab & Biotech Forum today.
-
TV: Astrazeneca väljer Sverige
Och vill se fler life science-grannar i Göteborg
-
Abbvie i topp för bästa arbetsplatserna 2020
Läkemedelsföretaget Abbvie rankas som femte mest trivsamma arbetsplatsen i rankningen Sveriges bästa arbetsplatser.
-
Life science management for hire
Do you need help getting your biotech company off and running? Camoleon is a new type of consultant that offers help with business and innovation management and...
-
Bakom de gröna ambitionerna
Många läkemedelsföretag inkluderar i dag ett miljötänk i tillverkningen av läkemedel. Men få är villiga att redovisa faktiska siffror i Life Science Swedens enk...
-
Orion cuts 205 jobs
The Finnish company Orion has completed its statutory negotiations. By this, personnel will be reduced by about 205 in Finland.
-
Swedish top scientists to EMBO
Two Swedish top scientists will have a really good chance to influence European life science research from now on. One is from the Karolinska Institutet, and on...
-
Athera signs production partnership
The companys novel cardiovascular product will be manufactured in Germany.
-
Reproducibility and handling in focus with new electronic pipette
The Eppendorf Xplorer electronic pipette has been developed with reproducibility in mind.
-
Medicult acquires embryo scanner
The Danish company Medicult signs an agreement with Novocellus to gain access to embryo selection technology.
-
Rapid and thorough homogenization of samples
MP Biomedicals presents the Fasprep-24 instrument, a new high-throughput model of the earlier Bio 101 Systems Fastprep homogenizer.
-
Finnish Innovation Fund gets new leader
The Supervisory Board of the Finnish Innovation Fund Sitra has appointed members of the Board, including a new president.
-
Upcoming event: New updates on drugs
At Medicon Valley Alliance venues in Copenhagen/Örestad April 1 2020 the meeting New updates in Drug Formulation & Bioavailability takes place for the for the eighth time.
-
New automated solution for flexible molecular assays
The fully integrated Qiasymphony is a new automated platform for flexible molecular testing.
-
Measurement of calorific content in a matter of minutes
The AC600 calorimeter from Leco uses rapid thermodynamics to analyze calorific content in five minutes.
-
Bio engineering breakthrough in Denmark
Brand new research makes BioGasol's cellulosic ethanol process even more competitive.
-
Control of blood vessels can treat obesity
Mice exposed to low temperatures develop more blood vessels in their adipose tissue and metabolise body fat more quickly, according to a new study from Karolinska Institutet.
-
Eli Lilly writes biotech fine history
The American biotech company Eli Lilly will pay US 1.415 billion to resolve allegations of off-label promotion of a dementia drug.